| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on October 29, 2002
From the Departments of Epidemiology (S.R.H., L.A.H., K.L.E., B.M.P., D.S.S.), Medicine (B.M.P., D.S.S.), and Biostatistics (T.L., R.A.K.), University of Washington, Seattle, Wash, and Department of Pathology (Z.T., J.P.D., R.P.T.), University of Vermont, Burlington, Vt. Z. Tang is now at the Department of Medicine, Thomas Jefferson University, Philadelphia, Pa. * To whom correspondence should be addressed. E-mail: heckbert{at}u.washington.edu..
Background--Genetic polymorphisms at codons 16 and 27 of the Methods and Results--A total of 808 black and 4441 white participants (mean age, 73 years) were genotyped for the Arg16Gly and Gln27Glu polymorphisms of the Conclusions--The Glu27 allele of the
Revised on February 7, 2003
Accepted on February 7, 2003
Susan R. Heckbert MD, PhD*,
2-Adrenergic Receptor Polymorphisms and Risk of Incident Cardiovascular Events in the Elderly
2-adrenergic receptor have been associated with altered response to sympathetic stimulation. We examined these polymorphisms in relation to cardiovascular event risk in the Cardiovascular Health Study.
2-adrenergic receptor. There were 702 incident coronary events, 438 ischemic strokes, and 1136 combined cardiovascular events during 7 to 10 years of follow-up. Allele frequencies differed by race but not by age or hypertension status. Glu27 carriers had a lower risk of coronary events than Gln27 homozygotes (hazard ratio, 0.82; 95% CI, 0.70 to 0.95), and there was a suggestion of decreased risk among Gly16 carriers compared with Arg16 homozygotes (hazard ratio, 0.88; 95% CI, 0.72 to 1.07). There was no association of
2-adrenergic receptor genotype with ischemic stroke or combined cardiovascular events.
2-adrenergic receptor was associated with a lower risk of incident coronary events in this elderly population.
This article has been cited by other articles:
![]() |
J. B. van der Net, J. van Etten, M. Yazdanpanah, G. M. Dallinga-Thie, J. J.P. Kastelein, J. C. Defesche, R. P. Koopmans, E. W. Steyerberg, and E. J.G. Sijbrands Gene-load score of the renin-angiotensin-aldosterone system is associated with coronary heart disease in familial hypercholesterolaemia Eur. Heart J., June 1, 2008; 29(11): 1370 - 1376. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Eisenach, D. R. Schroeder, T. L. Pike, C. P. Johnson, W. G. Schrage, E. M. Snyder, B. D. Johnson, V. D. Garovic, S. T. Turner, and M. J. Joyner Dietary sodium restriction and {beta}2-adrenergic receptor polymorphism modulate cardiovascular function in humans J. Physiol., August 1, 2006; 574(3): 955 - 965. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Zaroff, L. Pawlikowska, J. C. Miss, S. Yarlagadda, C. Ha, A. Achrol, P.-Y. Kwok, C. E. McCulloch, M. T. Lawton, N. Ko, et al. Adrenoceptor Polymorphisms and the Risk of Cardiac Injury and Dysfunction After Subarachnoid Hemorrhage Stroke, July 1, 2006; 37(7): 1680 - 1685. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. B. Liggett {beta}2-Adrenergic Receptor Polymorphisms and Sudden Cardiac Death: A Signal to Follow Circulation, April 18, 2006; 113(15): 1818 - 1820. [Full Text] [PDF] |
||||
![]() |
N. Sotoodehnia, D. S. Siscovick, M. Vatta, B. M. Psaty, R. P. Tracy, J. A. Towbin, R. N. Lemaitre, T. D. Rea, J. P. Durda, J. M. Chang, et al. {beta}2-Adrenergic Receptor Genetic Variants and Risk of Sudden Cardiac Death Circulation, April 18, 2006; 113(15): 1842 - 1848. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. Lanfear, P. G. Jones, S. Marsh, S. Cresci, H. L. McLeod, and J. A. Spertus {beta}2-Adrenergic Receptor Genotype and Survival Among Patients Receiving {beta}-Blocker Therapy After an Acute Coronary Syndrome JAMA, September 28, 2005; 294(12): 1526 - 1533. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Thakkinstian, M. McEvoy, C. Minelli, P. Gibson, B. Hancox, D. Duffy, J. Thompson, I. Hall, J. Kaufman, T.-f. Leung, et al. Systematic Review and Meta-Analysis of the Association between {beta}2-Adrenoceptor Polymorphisms and Asthma: A HuGE Review Am. J. Epidemiol., August 1, 2005; 162(3): 201 - 211. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. C. Trombetta, L. T. Batalha, M. U. P. B. Rondon, M. C. Laterza, E. Frazzatto, M. J. N. N. Alves, A. C. Santos, P. C. Brum, A. C. P. Barretto, A. Halpern, et al. Gly16 + Glu27 {beta}2-adrenoceptor polymorphisms cause increased forearm blood flow responses to mental stress and handgrip in humans J Appl Physiol, March 1, 2005; 98(3): 787 - 794. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Kirstein and P. A. Insel Autonomic Nervous System Pharmacogenomics: A Progress Report Pharmacol. Rev., March 1, 2004; 56(1): 31 - 52. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2003 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |